Buscador de publicaciones

Publicaciones

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, José Luis Dapena Díaz, Rives-Sola S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

    Frontiers in pediatrics . 8: 614521-614521.

    [doi:10.3389/fped.2020.614521]

  • Ortíz-Maldonado V, Rives-Sola S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballero-Baños M, Baumann T, Jordi Cid Colom, Garcia-Rey E, Llanos C, Torrebadell-Burriel M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català-Temprano A, Faura A, González EA, Español-Rego M, Klein-González N, Alsina L, Castro P, Jordán-García I, Fernández S, Ramos F, Suñé G, Perpiñá U, Canals JM, Lozano M, Trias E, Scalise A, Varea S, Sáez-Peñataro J, Torres F, Calvo G, Esteve J, Urbano-Ispizua Á, Manel Juan Otero and Delgado J.

    CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies

    MOLECULAR THERAPY . 29(2): 636-644. Nº de citas: 3

    [doi:10.1016/j.ymthe.2020.09.027]

  • Deyà-Martinez A, Alonso-Saladrigues A, Garcia, A. P., Faura, A., Torrebadell-Burriel M, Vlagea, A., Català-Temprano A, Esteve-Sole A, Manel Juan Otero, Rives-Sola S and Alsina L.

    Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

    BONE MARROW TRANSPLANTATION . 56(2): 376-386. Nº de citas: 3

    [doi:10.1038/s41409-020-01027-6]

  • Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garcés C, Alonso J, Barragán E, Fernández G, Hernández-Sánchez JM, Martín-Izquierdo M, Joan Maynou Fernández, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Sola S, Dapena JL, Ramírez M, Camós-Guijosa M and On Behalf Of The Group Of Leukemia Of The Spanish Society Of Pediatric Hematolog.

    Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

    Journal of Personalized Medicine . 10(4): 244.

    [doi:10.3390/jpm10040244]

  • Ortiz-Maldonado, V, Rives-Sola S, Alonso-Saladrigues A, Castella, M, Benitez-Ribas, D, Gonzalez, AE, Baumann, T, Diaz-Beya, M, Gine, E, Torrebadell-Burriel M, Montoro-Lorite, M, Garcia-Rey, E, Cid, J, Lozano, M, Castro, P, Jordán-García I, Esteve, J, Urbano-Ispizua, A, Manel Juan Otero and Delgado, J.

    CART19-BE-01: A EUROPEAN ACADEMIC TRIAL ON THE ADMINISTRATION OF ARI-0001 CELLS IN PATIENTS WITH CD19+LYMPHOPROLIFERATIVE DISORDERS

    HAEMATOLOGICA . 105: 83-84.

  • Sánchez-Martínez D, Baroni ML, Gutierrez-Agüera F, Roca-Ho H, Blanch-Lombarte O, González-García S, Torrebadell-Burriel M, Junca J, Ramírez-Orellana M, Velasco-Hernández T, Bueno C, Fuster JL, Prado JG, Calvo J, Uzan B, Cools J, Camós-Guijosa M, Pflumio F, Toribio ML and Menéndez P.

    Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

    Blood . 133(21): 2291-2304. Nº de citas: 23

    [doi:10.1182/blood-2018-10-882944]

  • Pascual-Pastó G, Bazan-Peregrino M, Gene-Olaciregui N, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa MG, Paco-Mercader S, Vilà-Ubach M, Cuadrado-Vilanova M, Castillo-Ecija H, Botteri G, García-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell-Burriel M, Roldan M, König A, Suñol M, Claverol J, Lavarino C, de Torres C, Fu L, Radvanyi F, Munier FL, Catala J, Mora J, Alemany R, Cascallo M, Chantada G and Montero-Carcaboso A.

    Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

    SCIENCE TRANSLATIONAL MEDICINE . 11(476): 9321. Nº de citas: 25

    [doi:10.1126/scitranslmed.aat9321]

  • Torrebadell-Burriel M, Diaz-Beya M, Kalko SG, Pratcorona M, Nomdedeu J, Navarro A, Gel B, Brunet S, Sierra J, Camós-Guijosa M and Esteve J.

    A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

    LEUKEMIA & LYMPHOMA . 59(10): 2394-2404. Nº de citas: 7

    [doi:10.1080/10428194.2017.1422859]

  • Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue Meda M, Pont-Martí S, Rives-Sola S and Camós-Guijosa M.

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.

    BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Nº de citas: 1

    [doi:10.1111/bjh.15436]

  • Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Montero-Carcaboso A.

    Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.

    JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de citas: 6

    [doi:10.1016/j.jconrel.2017.08.018]